Bulgaria's Sopharma Cuts 9-Mo Non-Cons Net Profit 30%, Sales in Russia Drop 11%

Bulgaria's Sopharma Cuts 9-Mo Non-Cons Net Profit 30%, Sales in Russia Drop 11%

Bulgarian drug maker Sopharma  said that its net profit fell by an annual 30.4% to 27.7 million levs ($16.1 million/14.2 million euro) in the first nine months of the year, as the company's sales declined, including an 11% drop in sales in Russia. Sopharma shares closed Tuesday's trading session on the Bulgarian Stock Exchange 2.09% lower at 3.74 levs.The company's sales revenue decreased 3.7% year-on-year to 152.1 million levs in January-September, Sopharma said in an interim financial statement. Sopharma's sales in Bulgaria shedded 3% on the year to 63.3 million levs, while sales in Europe declined 5% to 72.2 million levs, mainly due to the drop in exports to Russia. The drug maker's sales in other countries rose 2% to 16.5 million levs. The drug maker booked total operaing revenue of 169.7 million levs in the review period, down from 174.5 million levs in the comparable period of 2017.Sopharma's total operating expenses increased to 139.8 million levs from 131.3 million levs, on the back of higher expenses for hired services and salary costs. Sopharma has 10 production facilities with a portfolio of over 210 products.

Previous Next
Test Caption
Test Description goes like this
Cookies Preferences
Choose Type of Cookies You Accept Using

These cookies are required for the website to run and cannot be switched off. Such cookie are only set in response to actions made by you such as language, currency, login session, privacy preferences. You can set your browser to block these cookies but our site may not work then.

These cookies allow us to measure visitors traffic and see traffic sources by collecting information in data sets. They also help us understand which products and actions are more popular than others.

These cookies are usually set by our marketing and advertising partners. They may be used by them to build a profile of your interest and later show you relevant ads. If you do not allow these cookies you will not experience targeted ads for your interests.